Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Monconduit

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
European Journal of Haematology|January 1, 1996
Osteocalcin is not a marker of progress in multiple myeloma. Le Groupe d'Etude et de Recherche sur le Myélome (GERM)O Mejjad, X Le Loët, J P Basuyau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease. EORTC Lymphoma Cooperative Group. Groupe Pierre-et-Marie-CurieE M Noordijk, P Carde, A M Mandard, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1988
Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of CancerP Carde, M Hayat, J M Cosset, et al.
Annals of Internal Medicine|March 1, 1991
Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC Lymphoma Cooperative GroupM Henry-Amar, S Friedman, M Hayat, et al.
La Revue De Medecine Interne|January 1, 1990
[IgM myeloma: 6 cases and a review of the literature]A De Gramont, B Grosbois, J L Michaux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experienceJ M Burgers, R Somers, M Henry-Amar, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1991
Low-dose total body irradiation versus combination chemotherapy for lymphomas with follicular growth patternJ H Meerwaldt, P Carde, J M Burgers, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1990
Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative GroupM Henry-Amar, M Hayat, J H Meerwaldt, et al.
Blood|July 27, 2000
patients with the description of a new scoring system and its validation on 253 other patientsP Morel, M Monconduit, D Jacomy, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|June 1, 1987
[Treatment of multiple myeloma resistant to alkylating agents with dexamethasone, vincristine and adriamycin in continuous infusion]M Monconduit, X Le Loët, J F Bernard, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
European Journal of Haematology|January 1, 1996
Osteocalcin is not a marker of progress in multiple myeloma. Le Groupe d'Etude et de Recherche sur le Myélome (GERM)O Mejjad, X Le Loët, J P Basuyau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease. EORTC Lymphoma Cooperative Group. Groupe Pierre-et-Marie-CurieE M Noordijk, P Carde, A M Mandard, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1988
Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of CancerP Carde, M Hayat, J M Cosset, et al.
Annals of Internal Medicine|March 1, 1991
Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC Lymphoma Cooperative GroupM Henry-Amar, S Friedman, M Hayat, et al.
La Revue De Medecine Interne|January 1, 1990
[IgM myeloma: 6 cases and a review of the literature]A De Gramont, B Grosbois, J L Michaux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experienceJ M Burgers, R Somers, M Henry-Amar, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1991
Low-dose total body irradiation versus combination chemotherapy for lymphomas with follicular growth patternJ H Meerwaldt, P Carde, J M Burgers, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1990
Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative GroupM Henry-Amar, M Hayat, J H Meerwaldt, et al.
Blood|July 27, 2000
patients with the description of a new scoring system and its validation on 253 other patientsP Morel, M Monconduit, D Jacomy, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|June 1, 1987
[Treatment of multiple myeloma resistant to alkylating agents with dexamethasone, vincristine and adriamycin in continuous infusion]M Monconduit, X Le Loët, J F Bernard, et al.
Pageof 8